Please Wait

Applying Filters...

Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Prednicarbatum

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

10 API Suppliers, 2 USDMF, 3 CEP/COS, 2 KDMF, 4 NDC API, 7 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

23 FDF Dossiers, 4 FDA Orange Book, 15 Europe, 1 Canada, 3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 DKSH, 3 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 BASF, 1 CD Formulation, 1 Finar, 5 Microlex e.U, 1 Nitika Pharmaceutical Specialities, 1 Pluviaendo, 1 Prachin Chemical, 1 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Silverline Chemicals, 1 Valens Pharmachem, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

14 Topical, 8 Lubricants & Glidants, 7 Thickeners and Stabilizers, 5 Fillers, Diluents & Binders, 4 Emulsifying Agents, 3 Parenteral, 3 Solubilizers, 2 Film Formers & Plasticizers, 1 Taste Masking, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 1 Regulatory FDF Prices

MARKET PLACE

1 APIs

1 APIs

REF. STANDARDS & IMPURITIES

2 EDQM, 6 Others

Xls download

Filters

List of Suppliers

Reset Filter

Price Info

Product Main Page

Log in to download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Axplora	Germany	FARMABIOS S.p.A Gropello Cairoli IT	CEP 2011-144 - Rev 03	Prednicarbate	2024-08-19	Valid	Chemical		1467
29/11/2025	EUROAPI	France	EUROAPI GERMANY GmbH Frankfurt am Main DE	R1-CEP 2009-014 - Rev 01	Prednicarbate	2021-12-10	Valid	Chemical		1467

Contact us
to update this info

Prednicarbatum

Prednicarbatum

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

10 API Suppliers

2 USDMF

3 CEP/COS

2 KDMF

4 NDC API

7 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

23 FDF Dossiers

4 FDA Orange Book

15 Europe

1 Canada

3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

1 DKSH

3 Nanjing Well Pharmaceutical

2 Kirsch Pharma

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

8 BASF

1 CD Formulation

1 Finar

5 Microlex e.U

1 Nitika Pharmaceutical Specialities

1 Pluviaendo

1 Prachin Chemical

1 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Silverline Chemicals

1 Valens Pharmachem

1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

14 Topical

8 Lubricants & Glidants

7 Thickeners and Stabilizers

5 Fillers, Diluents & Binders

4 Emulsifying Agents

3 Parenteral

3 Solubilizers

2 Film Formers & Plasticizers

1 Taste Masking

1 API Stability Enhancers

1 Surfactant & Foaming Agents

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 Regulatory FDF Prices

MARKET PLACE

1 APIs

REF. STANDARDS & IMPURITIES

2 EDQM

6 Others

Filters

OINTMENT;TOPICAL - 0.1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CREAM;TOPICAL - 0.1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons